Cargando…

Loss of STIM2 in colorectal cancer drives growth and metastasis through metabolic reprogramming and PERK-ATF4 endoplasmic reticulum stress pathway

The endoplasmic reticulum (ER) stores large amounts of calcium (Ca(2+)), and the controlled release of ER Ca(2+) regulates a myriad of cellular functions. Although altered ER Ca(2+) homeostasis is known to induce ER stress, the mechanisms by which ER Ca(2+) imbalance activate ER stress pathways are...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathak, Trayambak, Benson, J. Cory, Johnson, Martin T., Xin, Ping, Abdelnaby, Ahmed Emam, Walter, Vonn, Koltun, Walter A., Yochum, Gregory S., Hempel, Nadine, Trebak, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10592933/
https://www.ncbi.nlm.nih.gov/pubmed/37873177
http://dx.doi.org/10.1101/2023.10.02.560521
Descripción
Sumario:The endoplasmic reticulum (ER) stores large amounts of calcium (Ca(2+)), and the controlled release of ER Ca(2+) regulates a myriad of cellular functions. Although altered ER Ca(2+) homeostasis is known to induce ER stress, the mechanisms by which ER Ca(2+) imbalance activate ER stress pathways are poorly understood. Stromal-interacting molecules STIM1 and STIM2 are two structurally homologous ER-resident Ca(2+) sensors that synergistically regulate Ca(2+) influx into the cytosol through Orai Ca(2+) channels for subsequent signaling to transcription and ER Ca(2+) refilling. Here, we demonstrate that reduced STIM2, but not STIM1, in colorectal cancer (CRC) is associated with poor patient prognosis. Loss of STIM2 causes SERCA2-dependent increase in ER Ca(2+), increased protein translation and transcriptional and metabolic rewiring supporting increased tumor size, invasion, and metastasis. Mechanistically, STIM2 loss activates cMyc and the PERK/ATF4 branch of ER stress in an Orai-independent manner. Therefore, STIM2 and PERK/ATF4 could be exploited for prognosis or in targeted therapies to inhibit CRC tumor growth and metastasis.